Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04055220 |
| Title | Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas (REGOSTA) |
| Acronym | REGOSTA |
| Recruitment | Recruiting |
| Gender | both |
| Phase | FDA approved |
| Variant Requirements | No |
| Sponsors | Centre Leon Berard |
| Indications | |
| Therapies | |
| Age Groups: | adult | child | senior |
| Covered Countries | FRA |